Background: Oleanolic acid, which can be isolated from many foods and medicinal plants, has been reported to possess diverse biological activities. It has been found that the acylation of the hydroxyl groups of the A-ring in the triterpene skeleton of oleanolic acid could be favorable for biological activities. The pyrimidinyl group has been constructed in many new compounds in various anti-tumor studies.
Background
Pentacyclic triterpenes, which are ubiquitous in the plant kingdom, have important ecological and agronomic functions, and contribute greatly to pest and disease resistance and to food quality in crop plants [1] . They are also applied in a variety of commercial uses in the food, cosmetic and pharmaceutical fields. For example, pentacyclic triterpene imberbic acid, isolated from Combretum imberbe (Engl. and Diels), has been found to have particularly potent activity against Mycobacterium fortuitum and Staphylococcus aureus [2] . Other pentacyclic triterpenes have been reported to possess antioxidant, antiproliferative, and pro-apoptotic capacities on MCF-7 human breast cancer cells [3] . They were also reported as a new class of glycogen phosphorylase inhibitors [4] and further proved to be multi-target therapeutic agents for the prevention and treatment of metabolic and vascular diseases [5] . Oleanolic acid (3β-hydroxyolean-12-en-28-oic acid, OA, 1, Fig. 1 ), which belongs to the family of oleanane pentacyclic triterpenes, has been isolated from more than 1620 plant species, including many food and medicinal plants [6] . It is among the major effective components of some well-known traditional chinese medicines (TCM) such as Rehmannia Six Formula (Liu Wei Di Huang Wan), which is one of the most commonly used Chinese herb formulas in the world. It has been used as a nonprescription antihepatitis drug for almost 35 years in China [7] . Oleanolic acid and its derivatives have recently attracted much attention due to their diverse biological activities [8] . For instance, oleanolic acid and its derivatives were reported to be inhibitors of protein tyrosine phosphatase 1B with cellular activities [9] and osteoclast formation [10, 11] . These compounds were also focused on cytotoxicity evaluation [12] . Furthermore, some synthetic oleanane triterpenoids (CDDO, CDDO-Me and CDDO-Im) have demonstrated potent antiangiogenic and antitumor activities in rodent cancer models [13, 14] . Other biological activities of oleanolic acid and its derivatives, including antiproliferative activity in solid tumor cells [15] , inhibition of α-glucosidase [16] , and others [6, 8] , were also revealed.
The importance of C-3 in the oleanolic acid skeleton was elucidated (Fig. 1) . The SAR analysis of oleanolic acid derivatives modified at C-3 and C-28 indicated that hydrogen-bond acceptor substitution at the C-3 position of oleanolic acid may be advantageous for the improvement of cytotoxicity against PC-3, A549 and MCF-7 cell lines [12] . Gnoatto found that the derivative with an acetylation at C-3 of the oleanolic acid backbone had much better activity against the L. amazonensis strain [17] . 3-Oxo oleanolic acid (3-oxo-olea-12-en-28-oic acid), a derivative of oleanolic acid modified at C-3, was found to significantly inhibit the growth of cancer cells derived from different tissues, particularly on melanoma in vivo [18] . Some other acyl compounds, generated from the modification of the hydroxyl groups of the A-ring in the triterpene skeleton of oleanolic acid and maslinic acid (MA, Fig. 1 ) with 10 different acyl groups, displayed cytotoxic effects against b16f10 murine melanoma cells and showed apoptotic effects with high levels of early and total apoptosis (up to 90%). These acyl compounds also exhibited better inhibition effects to anti-HIV-1-protease, with IC 50 values between 0.31 and 15.6 μM, which are 4-186 times lower than their non-acylated precursors [19] . Compound 2 ( Fig. 1) , un benzyl (2α,3β) 2,3-diacetoxy-olean-12-en-28-amide, exhibited much better cytotoxicity against human tumor cell lines compared with its deacylation product, while it showed a rather low cytotoxicity for human fibroblasts (WW030272) [20] .
On the other hand, pyrimidine has been widely used as an anti-tumor pharmacophore in medicinal chemical research [21] . For instance, some new pyridines and pyrazolo [1,5-α] pyrimidines exhibited potent anti-tumor cytotoxic activity in vitro against different human cell lines [22] . The evaluation of several ring-A fused hybrids of oleanolic acid against seven human cancer cell lines showed that the fused pyrimidine moiety seemed important to enhance the antiproliferative activity of oleanolic acid [23] . Thus, the pyrimidinyl group has been constructed in many new compounds in various anti-tumor studies [24] .
Results and discussion

Synthesis
Inspired by the cited evidence, in this study, we conjugated five different acyl OA derivatives (3a-3e) [15, 19, 20, 25, 26] with uracil. The synthetic routes are outlined in Schemes 1 and 2. The treatment of 1 (1 equiv) with anhydride (1.5 equiv) and DMAP (0.1 equiv) in anhydrous CH 2 Cl 2 /pyridine (1/7 = v/v) at room temperature afforded 3-O-acyl derivatives 3a-3c [15, 19, 20, 25] (64-89%). The treatment of 1 (1 equiv) with acyl chloride (3 equiv) and Et 3 N (3.5 equiv) in anhydrous THF at room temperature gave acyl derivatives 3d-3e [19, 26] (75-88%). The acyl oleanolic acid compounds (3a-3e, 1 equiv) were then first treated with oxalyl chloride (18 equiv) to give the corresponding acyl chloride, which was then treated with uracil (3 equiv) in the presence of Et 3 N to generate the corresponding acyl oleanolic acid-uracil conjugates (4a-4e, Scheme 2) in 11-60% yields. The structures of compounds 4a-4e were confirmed by NMR and mass spectra.
Cytotoxicity
As anti-tumor effects are the most classical activities of oleanolic acid and its derivatives [1, [27] [28] [29] , these conjugates have been evaluated by MTT assay [30, 31] against 5 adherent tumor cell lines (Hep-G2, A549, BGC-823, MCF-7 and PC-3) with 1 as the positive control. 5-Fluorouracil (5-FU), a medication used in the clinical treatment of cancer, is also a pyrimidine analog and was used as a positive control in this study. The results are presented in Table 1 .
The results showed that these compounds exhibited excellent antiproliferative activities against the tested cells, with the IC 50 values mainly under 10.0 μM, except for compounds 4a and 4b which showed no inhibition against the PC-3 cell line. In the Hep-G2, A549, BGC-823 and MCF-7 cell line assays, all the synthesized compounds displayed much better inhibition than that of 1 and 5-FU. With a propionyloxy group at C-3, compound 4b possessed the best inhibition activity against the Hep-G2 cell line, almost 5.5-fold and 20-fold stronger than 1 and 5-FU, respectively. With a dodecanoyloxy group at C-3, compound 4d showed the best inhibition activity against the A549 cell line, almost 60-fold and 84-fold stronger than 1 and 5-FU, respectively. Meanwhile, compound 4a, with an acetoxy group at C-3, exhibited the best inhibition activity against the MCF-7 cell line, more than 126-fold and 215-fold more effective than 1 and 5-FU respectively. Compounds 4a (acetoxy), 4b (propionyloxy) and 4e (palmitoxy) exhibited excellent antiproliferative activities against the BGC-823 cell line (IC 50 < 0.1 μM). Although compounds 4a (acetoxy) and 4b (propionyloxy) possessed good antiproliferative activities against the Hep-G2, A549, BGC-823 and MCF-7 cell lines, they showed no inhibition against the PC-3 cell line. In the PC-3 assay, the butyryloxy compound 4c exhibited the best antiproliferative activity, being 260-fold and 44-fold stronger than 1 and 5-FU, respectively. The results above reveal that in general, the acyl groups at the C-3 position of these uracil conjugates have primarily made a great contribution to the antiproliferative activities against the tested cell lines.
For further analysis, conjugate 4c was selected to determine its cytotoxicity selectivity and mechanism of growth inhibition on an adherent Hep-G2 cell line. The controls of the figures were reused from our previous work [32] .
Cytotoxicity selectivity
As shown in Fig. 2 , though the inhibition rate of 4c against human liver cell line HL-7702 (L-O2) at the Scheme 1 Synthesis of acyl oleanolic acid derivatives. Reagents and conditions: (i) anhydride, DMAP, anhydrous CH 2 Cl 2 /pyridine, rt (64-89%); (ii) acyl chloride, Et 3 N, anhydrous THF, rt (75-88%) Scheme 2 Synthesis of oleanolic acid-uracil conjugates, where n is the number of methylene groups in the acyl group concentration of 50 μM was equivalent to that of human hepatoma cell line Hep-G2, its inhibition rate against the HL-7702 cell line was only approximately 15% at the concentration of 10 μM, while the inhibition rate against the Hep-G2 cell line was up to 90% at the same concentration. Thus, it was exhibited that compound 4c showed strong cytotoxicity selectivity to human hepatocellular carcinoma cells in vitro at the therapeutically effective concentration.
Fluorescence staining
After sequentially staining with acridine orange (AO)/ ethidium bromide (EB) (Fig. 3) and Hoechst 33258 (Fig. 4) , the living cells were treated with compound 4c (2.5 and 5.0 μM, 24 h). As depicted in Fig. 3 , the living cells excluded EB and staining by AO caused a green color (Fig. 3a) , whereas the Hep-G2 cells treated with 4c had obviously changed (Fig. 3b, c) . Under fluorescence microscopy, early apoptosis cells were observed to emit orange or dark orange fluorescence, with nuclear morphological changes, which suggested that 4c could induce apoptosis in Hep-G2 cells. This is consistent with the results of Hoechst 33258 staining shown in Fig. 4 . The nuclei of the Hep-G2 cells retained the regular round contours in the control group (Fig. 4a) , and cells with smaller nuclei and condensed chromatin were rarely observed. It was found that the contours of some of the Hep-G2 cells became irregular even when they were exposed to 4c at lower concentration of 2.5 μM, accompanied with the nuclei being condensed (as the bright blue fluorescence indicates) and the apoptotic bodies appeared (Fig. 4b ). When treated with 4c at a higher concentration of 5.0 μM, the nuclei of many more cells were highly condensed and the apoptotic bodies were pervasive in the visual field (Fig. 4c) . These clear changes to the cell morphology suggested the significant cell apoptosis induction of 4c on Hep-G2 cells.
Cell cycle analysis
To confirm whether the decrease of cell viability was caused by cell cycle arrest, the Hep-G2 cells were treated with compound 4c for 48 h at different concentrations and then the cell cycle distribution was determined by a flow cytometry assay after propidium iodide (PI) staining (Fig. 5) . The results indicate that conjugate 4c enhanced the cell cycle arrest at the G1 phase at different concentrations, resulting in a concomitant population increase in the G1 phase (60.65-86.49, 87.66 and 73.54%), and declines in the cell population in the G2/M (13.83-2.09, 1.40 and 3.05%) and S-phases (25.52-11.42, 10.95 and 23.41%).
AnnexinV/propidium iodide assay
To determine whether the observed cell death induced by conjugate 4c was due to apoptosis or necrosis, the interactions of Hep-G2 cells with 4c were further investigated using an Annexin V-FITC/PI assay (Fig. 6) . The apoptosis ratios (including the early and late apoptosis ratios) of 4c measured at different concentration points were found to be 16.31% (2.5 μM) and 26.43% (5.0 μM), respectively, while that of the control was 4.06%. This revealed that 4c could mainly induce later period apoptosis in Hep-G2 cells.
Mitochondrial membrane potential detection
As the mitochondrial membrane potential (Δψ) has been considered a new antitumor target [33, 34] , the changes in Δψ in Hep-G2 cells (treated with conjugate 4c) stained with Rhodamine 123 indicated by flow-cytometric analysis were tested (Fig. 7) . The results indicated that 4c induced a marked concentration-dependent decrease of Rhodamine 123 fluorescence (decreasing from 86.2% to 85.8, 81.3 and 65.7% with the increase concentration of 4c). This indicated that compound 4c can induce mitochondrial membrane potential disruption in Hep-G2 cells.
Caspase-3/9 activity assay
FITC-DEVD-FMK (for caspase-3) and FITC-LEHD-FMK (for caspase-9) probe assays were carried out to determine the death signaling in the caspase family after treatment with 4c (5.0 μM, 24 h) in Hep-G2 cells. The proportion of activated-caspase-3 cells after 4c treatment was enhanced to 22.7% (Fig. 8a) , while that of activatedcaspase-9 cells was enhanced to 22.9% (Fig. 8b) . These results indicate that 4c could induce cell apoptosis by triggering caspase-3/9 activity in Hep-G2 cells.
Conclusions
Five acyl oleanolic acid-uracil conjugates were synthesized and their anti-tumor activities were evaluated. These conjugates exhibited excellent antiproliferative activities against the tested cells (Hep-G2, A549, Conjugate 4c was selected for further analysis including for its cytotoxicity selectivity and its mechanism of growth inhibition on the Hep-G2 cell line. The inhibition rate of 4c against the HL-7702 cell line was only approximately 15% (90% against Hep-G2) at the concentration of 10 μM, indicating that it had strong cytotoxicity selectivity to human hepatocellular carcinoma cells in vitro. The treatment of Hep-G2 cells with this compound, could induce changes in the permeability of the mitochondrial membrane, and thus cause a decline in the mitochondrial membrane potential. With the disruption of the mitochondrial membrane potential, changes in cellular morphology appeared as a result of significant apoptosis induction. Then, cell proliferation in the G1 phase was arrested and apoptotic signaling activated caspase-9. Caspase-9, as a protease, can activate the apoptotic effector caspase-3, eventually causing nuclear apoptosis. Further studies of the specific mechanisms of these compounds in human malignant tumors are currently underway. 
Methods
General
All commercially available solvents and reagents used were of analytical grade and were used without further purification. All commercial reagents were purchased from Aladdin (Shanghai) Industrial Corporation. Melting points were measured on a RY-1 melting point apparatus. 
Chemistry
General procedures for synthesis of oleanolic acid-uracil conjugates 4a-4e
To a solution of different acyl oleanolic acid compound (3a-3e, 0.2 mmol) in anhydrous CH 2 Cl 2 (3 mL) at 0 °C, oxalyl chloride (0.34 mL, 3.6 mmol) was added. After stirring at room temperature for 12 h, the mixture was evaporated, and co-evaporated with CH 2 Cl 2 (3 × 1 mL). The residue was dissolved in dry THF (3 mL), and then Et 3 N (1 mL, 0.7 mmol) and uracil (0.067 g, 0.6 mmol) were added at 0 °C. After stirring at r.t. for 24 h, the solvent was evaporated. The residue was then taken up in H 2 O (35 mL) and extracted with CH 2 Cl 2 (3 × 20 mL). The combined organic layers were washed with H 2 O and brine, dried with MgSO 4 , filtered and concentrated to give a crude product. The crude product was purified by flash column chromatography to afford the corresponding product (4a-4e) respectively (Additional file 1).
Compound 4a
Compound 4a was prepared from 3a [15, 19, 20] (1.000 g, 2.00 mmol) and uracil (0.673 g, 6.00 mmol) according to the general procedure. The residue was purified by flash column chromatography (Petroleum ether:EtOAc = 4: 1). Yield: 0.349 g, 29%, white solid, mp 209-211 °C. 
Compound 4b
Compound 4b was prepared from 3b [19, 25] 
Compound 4c
Compound 4c was prepared from 3c [19, 25] 
Compound 4d
Compound 4d was prepared from 3d [19] 
Compound 4e
Compound 4e was prepared from 3e [26] 
Cell lines and culture
The human hepatocellular cell line Hep-G2, human lung cancer cell line A549, human gastric tumor cell line BGC-823, human breast tumor cell line MCF-7, human prostate cancer cell line PC-3 and human hepatocyte cell line HL-7702, these adherent cells were purchased from the Cell Bank of Type Culture Collection of the Chinese Academy of Sciences (Shanghai) and cultured in DMEM medium supplemented with 10% FCS (Fetal Calf Serum). The cells were incubated in an atmosphere of 5% CO 2 and 95% air at 37 °C.
MTT assay
The MTT assay was carried out according to a description in a published study [30, 31] . Cells were seeded in 96-well plates and incubated in a CO 2 incubator at 37 °C. The tested compounds were dissolved in fresh culture medium with 2% DMSO to afford various concentrations (100, 50, 10, 5, 1 or 0.1 μmol/L). When the cells adhered, compounds at different concentrations were added to every well. The control wells contained medium supplemented with 2% DMSO. After incubation for another 72 h, 20 μL MTT (5%) was added to each well, and the cells were incubated for an additional 4 h at 37 °C. At last, the medium was removed carefully and dimethyl sulfoxide (100 μL) was added to each well. Then the plate was kept on a shaker for 10 min to mix these solutions properly. The absorbance of each well was scanned with an electrophotometer at 570 nm. Each concentration treatment was performed in triplicate wells. The IC 50 values were estimated by fitting the inhibition data to a dosedependent curve using a logistic derivative equation.
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